WinstonWınston
Back
Monash IVF Group Limited logo

Monash IVF Group Limited

MVF.AX
41
Medical - Diagnostics & Research · Healthcare
Price
A$0.74
+0.02 (+2.76%)
Market Cap
A$290.3M
Exchange
Australian Securities Exchange
Winston Score
41
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Strong
Stability
Good
Valuation
Strong
Dividends
Weak

Winston Score History

The full picture

Monash IVF Group is an Australian fertility clinic company that helps people have babies through in vitro fertilization (IVF) and related treatments. Its core services include IVF cycles, fertility assessments, ultrasound diagnostics, and genetic testing of embryos. The company operates across Australia and Malaysia, serving patients who need medical assistance to conceive.

Monash IVF makes money by charging patients and private health insurers for each fertility treatment or diagnostic service performed. It runs around 30 clinic locations, primarily in Australia, making it one of the larger fertility clinic networks in the country. The company benefits from a degree of scale and specialist medical expertise that is difficult to replicate quickly, but it faces real competition from other fertility groups like Virtus Health. The key growth driver is rising demand for fertility services as more people delay having children, though the business is sensitive to any changes in government rebates or private health insurance coverage that help patients afford treatment.

Share count broadly stable

+0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 390.9M (2021) → 391.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
24.2%
Thin — 24.2% gross margin
Profit after running costs
Operating Margin
10.8%
Modest — 10.8% operating margin
Return on the money invested
ROCE
6.8%
Weak — 6.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-0.2%
Shrinking sales (-0.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
153%
Turns 153% of profit into real cash
Spare cash per sale
FCF Margin
3.4%
Thin free cash flow (3.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.78
Moderate — manageable debt (0.78)
Covers its interest
Interest Cover
3.57x
Tight — interest eats into profit (3.6x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
19.2x
Fair value — P/E 19.2

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+5.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (19.2 → 13.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.75%
Small dividend — 1.75% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial